Patents Assigned to Metabolic Explorer
  • Patent number: 11814663
    Abstract: The present invention concerns a new mutant strain of Clostridium acetobutylicum comprising attenuated glycerol kinase activity. In addition, the present invention concerns a consortium of Clostridium comprising at least said mutant strain and at least one other species of Clostridium chosen among C. sporogenes and C. sphenoides. As this modified strain may be adapted for growth and for the production of 1,3-propanediol in an appropriate culture medium with high glycerol content, the invention also relates to a method for the production of 1,3-propanediolandbutyric acid, by culturing at least this mutant strain in an appropriate culture medium.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: November 14, 2023
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Céline Raynaud, Laurence Dumon-Seignovert, Nadège Dumoulin
  • Publication number: 20230357808
    Abstract: The present invention relates to a microorganism genetically modified for improved production of alanine, wherein the microorganism expresses a heterologous alaD gene coding an alanine dehydrogenase and has reduced Lrp transcription factor activity and/or expression. The present invention also relates to a method for the production of alanine using said microorganism.
    Type: Application
    Filed: September 1, 2021
    Publication date: November 9, 2023
    Applicant: METABOLIC EXPLORER
    Inventors: Laurence DUMON-SEIGNOVERT, Céline RAYNAUD
  • Patent number: 11655486
    Abstract: The present invention concerns a new method for the production of 1,3-propanediol comprising culturing a recombinant microorganism converting glycerol into 1,3-propanediol and overexpressing the hcpR and/or frdX gene on a medium comprising glycerine. A recombinant microorganism for the production of 1,3 propanediol from glycerol, wherein said microorganism converts glycerol into 1,3-propanediol and 10 overexpresses the hcpR and/or the frdX gene.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: May 23, 2023
    Assignee: METABOLIC EXPLORER
    Inventors: Céline Raynaud, Olivier Tourrasse, Nadège Dumoulin
  • Publication number: 20230151398
    Abstract: The present invention relates to a microorganism genetically modified for production of ectoine, wherein said microorganism comprises the following modifications: expression of a heterologous gene ectA encoding a diaminobutyric acid acetyltransferase having at least 90% similarity with SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 or SEQ ID NO: 5, a heterologous gene ectB encoding a diaminobutyric acid aminotransferase having at least 90% similarity with SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9 or SEQ ID NO: 10, a heterologous gene ectC encoding an ectoine synthase having at least 90% similarity with SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14 or SEQ ID NO: 15 and deletion of pykA and pykF genes. The present invention also relates to a method for the production of ectoine using said microorganism.
    Type: Application
    Filed: February 8, 2021
    Publication date: May 18, 2023
    Applicant: METABOLIC EXPLORER
    Inventors: Laurence DUMON-SEIGNOVERT, Céline RAYNAUD, Thomas DESFOUGERES
  • Patent number: 11293039
    Abstract: The invention relates to a method for producing salts of butyric acid, lactic acid, propionic acid, valeric acid, acetic acid, glycolic acid, sorbic acid, fumaric acid, formic acid, malic acid, tartaric acid, citric acid, derivatives of said organic acids and mixtures thereof, comprising at least the successive steps of: •i) culturing a microorganism in an appropriate culture medium comprising a carbon source and a nitrogen source, during a sufficient time to obtain a fermentation broth comprising the organic acid(s); •ii) pre-treating said fermentation broth comprising at least clarification of the fermentation broth and separation of organic acids by evaporation of the clarified fermentation broth and then condensation of the volatile fraction containing organic acids (CVAF); •v) adding inorganic bases to said CVAF •vii) eliminating the remaining water of the CVAF, and recovering the organic acid salts.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: April 5, 2022
    Assignee: METABOLIC EXPLORER
    Inventors: Antoine Sevenier, Cédric Colomb, Benjamin Martin
  • Patent number: 11162082
    Abstract: Provided is a genetically modified microorganism for the production of a derivative of 4-hydroxy-2-ketobutyrate selected in the group consisting of 1,3-propanediol, 3-hydroxypropionaldehyde, 3-hydroxypropionate and 2,4-dihydroxybutyrate, the microorganism further having a gene coding for a mutant phosphoserine aminotransferase having an improved L-homoserine aminotransferase activity converting by transamination L-homoserine into 4-hydroxy-2-ketobutyrate. Also provided is a method for the production of derivatives of 4-hydroxy-2-ketobutyrate selected in the group consisting of 1,3-propanediol, 3-hydroxypropionaldehyde, 3-hydroxypropionate and 2,4-dihydroxybutyrate by culturing the genetically modified microorganism in a culture medium and recovering the desired derivative.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: November 2, 2021
    Assignee: METABOLIC EXPLORER
    Inventors: An-Ping Zeng, Chengwei Ma, Yujun Zhang
  • Publication number: 20210254108
    Abstract: The present invention concerns a new mutant strain of Clostridium acetobutylicum comprising attenuated glycerol kinase activity. In addition, the present invention concerns a consortium of Clostridium comprising at least said mutant strain and at least one other species of Clostridium chosen among C. sporogenes and C. sphenoides. As this modified strain may be adapted for growth and for the production of 1,3-propanediol in an appropriate culture medium with high glycerol content, the invention also relates to a method for the production of 1,3-propanediol and butyric acid, by culturing at least this mutant strain in an appropriate culture medium.
    Type: Application
    Filed: August 9, 2019
    Publication date: August 19, 2021
    Applicant: METABOLIC EXPLORER
    Inventors: Wanda DISCHERT, Céline RAYNAUD, Laurence DUMON-SEIGNOVERT, Nadège DUMOULIN
  • Publication number: 20210198639
    Abstract: The present invention concerns a genetically modified microorganism for the production of a derivative of 4-hydroxy-2-ketobutyrate selected in the group consisting of 1,3-propanediol, 3-hydroxypropionaldehyde, 3-hydroxypropionate and 2,4-dihydroxybutyrate, said microorganism further comprising a gene coding for a mutant phosphoserine aminotransferase having an improved L-homoserine aminotransferase activity converting by transamination L-homoserine into 4-hydroxy-2-ketobutyrate. The invention also concerns a method for the production of derivatives of 4-hydroxy-2-ketobutyrate selected in the group consisting of 1,3-propanediol, 3-hydroxypropionaldehyde, 3-hydroxypropionate and 2,4-dihydroxybutyrate by culturing said genetically modified microorganism in a culture medium and recovering the desired derivative.
    Type: Application
    Filed: October 10, 2018
    Publication date: July 1, 2021
    Applicant: METABOLIC EXPLORER
    Inventors: An-Ping ZENG, Chengwei MA, Yujun ZHANG
  • Patent number: 10982237
    Abstract: The present invention relates to a microbial consortium, especially adapted for growth and production of 1,3-propanediol from a culture medium with high glycerinecontent and specifically with a high concentration of industrial glycerine. More particularly, this microbial consortium comprises at least one strain C. acetobutylicum and at least one strain chosen among strains of C. sporogenes and/or strains of C. sphenoides. The invention also relates to a method for the production of 1,3-propanediol by culturing this microbial consortium resulting in a co-culture of these particular different microorganisms.
    Type: Grant
    Filed: February 19, 2018
    Date of Patent: April 20, 2021
    Assignee: METABOLIC EXPLORER
    Inventors: Olivier Tourrasse, Céline Raynaud
  • Patent number: 10961499
    Abstract: The present invention relates to a new method for the production of a molecule of interest by conversion of a source of carbon in a fermentative process comprising culturing a microorganism genetically modified for the production of molecule of interest, wherein said microorganism comprises functional genes coding PTS carbohydrate utilization system and wherein the expression of proteins regulated the expression of phosphoenolpyruvate synthase (PPS) is down-regulated. The present invention also relates to the genetically modified microorganism used in the method of the invention.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: March 30, 2021
    Assignee: METABOLIC EXPLORER
    Inventors: Gwénaëlle Corre, Céline Raynaud
  • Patent number: 10889840
    Abstract: The present invention relates to new methylglyoxal reductase (MGR) enzymes which are useful for efficiently converting methylglyoxal into hydroxyacetone. The invention more particularly relates to a method for efficiently converting methylglyoxal into hydroxyacetone using said enzymes, to a method for producing 1,2-propanediol using a microorganism overexpressing said enzymes, and to said microorganism.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: January 12, 2021
    Assignee: METABOLIC EXPLORER
    Inventors: Laetitia Faure, Gwenaëlle Corre, Céline Raynaud, Laurence Dumon-Seignovert
  • Patent number: 10858675
    Abstract: The present invention relates to a recombinant microorganism capable of producing 2,4-dihydroxybutyrate, which is characterized by an increased cellular export, and preferably by a decreased cellular import, of said 2,4 DHB. The invention also relates to a method for the optimized production of 2,4-dihydroxybutyrate by culturing said microorganism in a fermentation medium and recovering 2,4-DHB from said medium.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: December 8, 2020
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Laurence Dumon-Seignovert, Perrine Vasseur, Gwénaëlle Bestel-Corre, Philippe Soucaille
  • Publication number: 20200370072
    Abstract: The present invention concerns a new method for the production of 1,3-propanediol comprising culturing a recombinant microorganism converting glycerol into 1,3-propanediol and overexpressing the hcpR and/or frdX gene on a medium comprising glycerine. A recombinant microorganism for the production of 1,3 propanediol from glycerol, wherein said microorganism converts glycerol into 1,3-propanediol and 10 overexpresses the hcpR and/or the frdX gene.
    Type: Application
    Filed: August 3, 2018
    Publication date: November 26, 2020
    Applicant: METABOLIC EXPLORER
    Inventors: Céline RAYNAUD, Olivier TOURRASSE, Nadège DUMOULIN
  • Patent number: 10801050
    Abstract: The present invention relates to a genetically modified microorganism for the fermentative conversion of levulinic acid into propionyl-CoA and acetyl-CoA, and to a fermentation process for performing said conversion.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: October 13, 2020
    Assignee: METABOLIC EXPLORER
    Inventors: Gwenaëlle Corre, Laurence Dumon-Seignovert, Philippe Soucaille
  • Patent number: 10774320
    Abstract: The present invention relates to methods and recombinant microorganisms useful for the production of glycolic acid and/or glyoxylic acid. The methods of the invention involve either only one step of fermentation of the modified microorganisms of the invention or one step of fermentation of the modified microorganisms of the invention and one step of either biological or chemical conversion of the glycolic acid or of the glyoxylic acid, the microorganism of the invention over expressing a phosphoketolase gene.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: September 15, 2020
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Gwenaëlle Corre, Philippe Soucaille
  • Patent number: 10731137
    Abstract: The present invention relates to new lactaldehyde reductase (LAR) enzymes useful for the production of 1,2-propanediol and to microorganisms overexpressing said enzymes. The invention also relates to a method for producing 1,2-propanediol by converting lactaldehyde into 1,2-propanediol with said enzymes.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: August 4, 2020
    Assignee: METABOLIC EXPLORER
    Inventors: Gwénaëlle Corre, Pascale Aliprandi
  • Publication number: 20200231995
    Abstract: The invention relates to a method for producing salts of butyric acid, lactic acid, propionic acid, valeric acid, acetic acid, glycolic acid, sorbic acid, fumaric acid, formic acid, malic acid, tartaric acid, citric acid, derivatives of said organic acids and mixtures thereof, comprising at least the successive steps of: ?i) culturing a microorganism in an appropriate culture medium comprising a carbon source and a nitrogen source, during a sufficient time to obtain a fermentation broth comprising the organic acid(s); ?ii) pre-treating said fermentation broth comprising at least clarification of the fermentation broth and separation of organic acids by evaporation of the clarified fermentation broth and then condensation of the volatile fraction containing organic acids (CVAF); ?v) adding inorganic C bases to said CVAF?vii) eliminating the remaining water of the CVAF, and recovering the organic acid salts.
    Type: Application
    Filed: October 1, 2018
    Publication date: July 23, 2020
    Applicant: METABOLIC EXPLORER
    Inventors: Antoine SEVENIER, Cédric COLOMB, Benjamin MARTIN
  • Patent number: 10689671
    Abstract: The present invention relates to a recombinant microorganism useful for the production of 1,2-propanediol and process for the preparation of 1,2-propanediol. The microorganism of the invention is modified in a way that the 1,2-propanediol production is improved by enhancing NADPH dependent HAR activity.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: June 23, 2020
    Assignee: METABOLIC EXPLORER
    Inventors: Pascale Aliprandi, Emilie Navarro, Céline Raynaud, Gwénaëlle Bestel Corre, Philippe Soucaille
  • Publication number: 20200181652
    Abstract: The present invention relates to new methylglyoxal reductase (MGR) enzymes which are useful for efficiently converting methylglyoxal into hydroxyacetone. The invention more particularly relates to a method for efficiently converting methylglyoxal into hydroxyacetone using said enzymes, to a method for producing 1,2-propanediol using a microorganism overexpressing said enzymes, and to said microorganism.
    Type: Application
    Filed: December 29, 2017
    Publication date: June 11, 2020
    Applicant: METABOLIC EXPLORER
    Inventors: Laetitia FAURE, Gwenaëlle CORRE, Céline RAYNAUD, Laurence DUMON-SEIGNOVERT
  • Publication number: 20190367898
    Abstract: The present invention relates to methods and recombinant microorganisms useful for the production of glycolic acid and/or glyoxylic acid. The methods of the invention involve either only one step of fermentation of the modified microorganisms of the invention or one step of fermentation of the modified microorganisms of the invention and one step of either biological or chemical conversion of the glycolic acid or of the glyoxylic acid, the microorganism of the invention over expressing a phosphoketolase gene.
    Type: Application
    Filed: January 26, 2018
    Publication date: December 5, 2019
    Applicant: METABOLIC EXPLORER
    Inventors: Wanda DISCHERT, Gwenaëlle CORRE, Philippe SOUCAILLE